Viewing Study NCT03291418


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2025-12-26 @ 3:54 AM
Study NCT ID: NCT03291418
Status: COMPLETED
Last Update Posted: 2018-06-06
First Post: 2017-09-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Sponsor: Antibe Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module